Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
Article CAS PubMed Google Scholar
Lehre KP, Danbolt NC (1998) The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J Neurosci 18:8751–8757
Article CAS PubMed PubMed Central Google Scholar
Rimmele TS, Rosenberg PA (2016) GLT-1: the elusive presynaptic glutamate transporter. Neurochem Int 98:19–28
Article CAS PubMed PubMed Central Google Scholar
Benarroch EE (2018) Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: emerging mechanisms. Neurology 91:125–32
Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K et al (2020) The dual role of glutamatergic neurotransmission in Alzheimer’s disease: from pathophysiology to pharmacotherapy. Int J Mol Sci 21:1–29
Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A (2013) Amyloid beta, glutamate, excitotoxicity in Alzheimer’s disease: Are we on the right track? CNS Neurosci Ther 19:549–555
Article CAS PubMed PubMed Central Google Scholar
Li S, Selkoe DJ (2020) A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer’s brain. J Neurochem 154:583–597
Article CAS PubMed PubMed Central Google Scholar
Parsons MP, Raymond LA (2014) Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 82:279–293
Article CAS PubMed Google Scholar
Rudy CC, Hunsberger HC, Weitzner DS, Reed MN (2015) The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer’s disease. Aging Dis 6:131–148
Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer’s disease. J Alzheimer’s Dis 57:1041–1048
Lewerenz J, Maher P (2015) Chronic glutamate toxicity in neurodegenerative diseases-What is the evidence? Front Neurosci 9:1–20
Zott B, Konnerth A (2023) Impairments of glutamatergic synaptic transmission in Alzheimer’s disease. Semin Cell Dev Biol 139:24–34
Article CAS PubMed Google Scholar
Danbolt NC, Furness DN, Zhou Y (2016) Neuronal vs glial glutamate uptake: resolving the conundrum. Neurochem Int 98:29–45
Article CAS PubMed Google Scholar
Lehre KR, Rusakov DA (2002) Asymmetry of glia near central synapses favors presynaptically directed glutamate escape. Biophys J 83:125–134
Article CAS PubMed Google Scholar
Gavrilov N, Golyagina I, Brazhe A, Scimemi A, Turlapov V, Semyanov A (2018) Astrocytic coverage of dendritic spines, dendritic shafts, and axonal boutons in hippocampal neuropil. Front Cell Neurosci 12:1–16
Ferrarese C, Begni B, Canevari C, Zoia C, Piolti R, Frigo M et al (2000) Glutamate uptake is decreased in platelets from Alzheimer’s disease patients. Ann Neurol 47:641–643
Article CAS PubMed Google Scholar
Hefendehl JK, LeDue J, Ko RWY, Mahler J, Murphy TH, MacVicar BA (2016) Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging. Nat Commun 7:13441
Article CAS PubMed Google Scholar
Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009) Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62:788–801
Article CAS PubMed Google Scholar
Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer’s disease. Ann Neurol 40:759–766
Article CAS PubMed Google Scholar
Mookherjee P, Green PS, Watson GS, Marques MA, Tanaka K, Meeker KD et al (2011) GLT-1 loss accelerates cognitive deficit onset in an Alzheimer’s disease animal model. J Alzheimer’s Dis 26:447–455
Schallier A, Smolders I, Van Dam D, Loyens E, De Deyn PP, Michotte A et al (2011) Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer’s disease. J Alzheimer’s Dis JAD 24:287–300
Article CAS PubMed Google Scholar
Scimemi A, Meabon JS, Woltjer RL, Sullivan JM, Diamond JS, Cook DG (2013) Amyloid-β1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1. J Neurosci 33:5312–5318
Article CAS PubMed PubMed Central Google Scholar
Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, Dodd PR (2011) Glutamate transporter variants reduce glutamate uptake in Alzheimer’s disease. Neurobiol Aging 32:553.e1-553.e11
Brymer KJ, Barnes JR, Parsons MP (2021) Entering a new era of quantifying glutamate clearance in health and disease. J Neurosci Res. https://doi.org/10.1002/jnr.24810
Takahashi K, Foster JB, Lin CLG (2015) Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease. Cell Mol Life Sci 72:3489–3506
Article CAS PubMed Google Scholar
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R et al (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39:409–421
Article CAS PubMed Google Scholar
Pinky NF, Wilkie CM, Barnes JR, Parsons MP (2018) Region-and activity-dependent regulation of extracellular glutamate. J Neurosci 38:5351–5366
Article CAS PubMed PubMed Central Google Scholar
Barnes JR, Mukherjee B, Rogers BC, Nafar F, Gosse M, Parsons MP (2020) The relationship between glutamate dynamics and activity-dependent synaptic plasticity. J Neurosci 40:2793–2807
Article CAS PubMed PubMed Central Google Scholar
Botterill JJ, Gerencer KJ, Vinod KY, Alcantara-Gonzalez D, Scharfman HE (2021) Dorsal and ventral mossy cells differ in their axonal projections throughout the dentate gyrus of the mouse hippocampus. Hippocampus 31:522–539
Article CAS PubMed PubMed Central Google Scholar
Wilkie CM, Barron JC, Brymer KJ, Barnes JR, Nafar F, Parsons MP (2021) The effect of GLT-1 upregulation on extracellular glutamate dynamics. Front Cell Neurosci 15:1–16
Wilkie CM, Barnes JR, Benson CLM, Brymer KJ, Nafar F, Parsons MP (2020) Hippocampal synaptic dysfunction in a mouse model of huntington disease is not alleviated by ceftriaxone treatment. Eneuro. https://doi.org/10.1523/ENEURO.0440-19.2020
Article PubMed PubMed Central Google Scholar
Ting JT, Lee BR, Chong P, Soler-Llavina G, Cobbs C, Koch C et al (2018) Preparation of acute brain slices using an optimized N-Methyl-D-glucamine protective recovery method. JoVE J Vis Exp 132:e53825
Gao JX, Liu LZ, Liu C, Fan SJ, Liu LR, Liu SF et al (2020) GLT-1 knockdown inhibits ceftriaxone-mediated improvements on cognitive deficits, and GLT-1 and xCT expression and activity in APP/PS1 AD mice. Front Aging Neurosci 12:1–12
Lazic SE (2010) The problem of pseudoreplication in neuroscientific studies: Is it affecting your analysis? BMC Neurosci 11:5
Article PubMed PubMed Central Google Scholar
Armbruster M, Hanson E, Dulla CG (2016) Glutamate clearance is locally modulated by presynaptic neuronal activity in the cerebral cortex. J Neurosci 36:10404–10415
Article CAS PubMed PubMed Central Google Scholar
Unger F, Konnerth A, Zott B (2021) Population imaging of synaptically released glutamate in mouse hippocampal slices. STAR Protoc 2:100877
Article CAS PubMed PubMed Central Google Scholar
Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44:5–21
Article CAS PubMed Google Scholar
Nicoll RA, Review A (2017) Brief history of long-term potentiation. Neuron 93:281–90
留言 (0)